INTERNATIONAL PATENT: SENTI BIOSCIENCES, INC., BLUEROCK THERAPEUTICS LP FILES APPLICATION FOR "PHENOTYPE LOCKING AND SWITCHING MECHANISMS IN STEM CELLS AND STEM-CELL DERIVED IMMUNE CELLS"

GENEVA, Jan. 7 -- SENTI BIOSCIENCES, INC. (2 Corporate Drive, First FloorSouth San Francisco, California 94080), BLUEROCK THERAPEUTICS LP (238 Main Street, Floor 3Cambridge, Massachusetts 02142) filed a patent application (PCT/US2025/035053) for "PHENOTYPE LOCKING AND SWITCHING MECHANISMS IN STEM CELLS AND STEM-CELL DERIVED IMMUNE CELLS" on Jun 24, 2025. With publication no. WO/2026/006316, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Frances Deen (c/o SENTI BIOSCIENCES, INC.2 Corporate Drive, First FloorSouth San...